Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

255 Views

Session: Infections in Transplant and Hematologic Malignancy Patients, Part 2

634 - Association of pre-transplant CD4 count on post-renal transplant infectious outcomes among persons with HIV

Saturday, October 19, 2024

3:45 PM – 4:00 PM US PT

Location: 404 AB

Presenting Author(s)

Rebecca H. Burns, MD

Transplant and Oncology Infectious Diseases, Associate Professor of Medicine
Warren Alpert Medical School of Brown University
Boston, MA, United States

Slides

Co-Author(s)

CR

Christin Rogers Marks, PharmD

Beth Israel Deaconess Medical Center
Norton, Massachusetts, United States
SB

Sara Booth, MPH

Biostatistician I
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Christine Durand, MD (she/her/hers)

Associate Professor
Johns Hopkins
Baltimore, MD, United States
Jonathan Hand, MD

Section Head, Transplant Infectious Diseases
Ochsner Health
New Orleans, LA, United States
Maheen Abidi, MD, FAST

Associate Professor
University of Colorado Anschutz Medical Campus
Denver, CO, United States
Maricar F. Malinis, MD (she/her/hers)

Associate Professor of Medicine
Vanderbilt University Medical Center, TN, United States
BB

Brittany Barnaba, MS, RN

Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
MP

Martha Pavlakis, MD

Associate Professor
Beth Israel Deaconess Medical Center, Harvard Medical School
Boston, MA, United States
Douglas Krakower, MD (he/him/his)

Associate Professor of Medicine
Harvard Medical School
Boston, MA, United States
CA

Carolyn D. Alonso, MD

Principal Investigator
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
AL

Audrey Le Mahajan, MD

Instructor
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure(s):

Rebecca H. Burns, MD: No financial relationships to disclose

Christin Rogers Marks, PharmD: Novo Nordisk: Current employee

Sara Booth, MPH: No financial relationships to disclose

Christine Durand, MD: Gilead: Grant/Research Support, Honoraria

Jonathan Hand, MD: AstraZeneca: Grant/Research Support; Janssen: Grant/Research Support; Pfizer: Advisor/Consultant, Grant/Research Support; Scynexis: Grant/Research Support

Maheen Abidi, MD, FAST: No financial relationships to disclose

Maricar F. Malinis, MD: Moderna ( concluded): Advisor/Consultant; Paratek Pharmaceuticals, Inc.: Honoraria

Brittany Barnaba, MS, RN: No financial relationships to disclose

Martha Pavlakis, MD: Merck: Advisor/Consultant; Vertex: Advisor/Consultant

Douglas Krakower, MD: FluidForm Bio: Stocks/Bonds (Private Company) (); Gilead: Grant/Research Support (); Matchbox Health: Stocks/Bonds (Private Company) (); Medscape: Funding to develop educational content (); Merck: Grant/Research Support (); PrEP4All: Travel to meeting on PrEP acccess (Terminated, February 13, 2024)

Carolyn D. Alonso, MD: AiCuris: Advisor/Consultant; Cidara: Advisor/Consultant; Ferring: Travel support to present data at meeting; Merck: Advisor/Consultant; Pfizer: Advisor/Consultant

Audrey Le Mahajan, MD: AstraZeneca: Grant/Research Support